Status:
WITHDRAWN
Doxycycline Versus Standard Care to Prevent Seroma Formation
Lead Sponsor:
Northwell Health
Conditions:
Seroma
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
A seroma is a collection of fluid other than pus or blood which forms through the division of numerous lymphatic channels, which normally drain the interstitial space under the skin. These channels be...
Eligibility Criteria
Inclusion
- Male and female candidates (\>18 and \<85 years of age) undergoing Cardiopulmonary By-Pass via Femoral/Groin access as part of their routine cardiothoracic scheduled procedure will be approached for their interest in participation in the study.
Exclusion
- A history of allergic reaction to doxycycline (Adoxa, Doryx, Oracea, Vibramycin) or any classes of tetracyclines- demeclocycline (Declomycin), or minocycline (Dynacin, Minocin, Solodyn, Vectrin).
- Patients who are not undergoing Cardiopulmonary By-Pass through femoral access.
- Active infection in the groin region.
- Females who are pregnant or lactating and breast feeding.
- Who do not wish to participate in the study.
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01188954
Start Date
January 1 2010
End Date
November 1 2012
Last Update
April 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Staten Island University Hospital
Staten Island, New York, United States, 10305